Article | February 11, 2016

Accelerating Clinical Trials From The Outset

 Accelerating Clinical Trials From The Outset

By Craig Morgan NZCS, MBA (Hons), PMP, goBalto, Inc.

With thousands of investigational pharmaceuticals, biologics, and medical devices in clinical trials, there is intense pressure to speed them along so the more promising candidates will come to market sooner. Patients across the globe are waiting for these new therapies, but complicated study protocols, globalization, and paper-based methods of conducting trials continue to delay market entry. Fortunately, the current approach to clinical trials, widely acknowledged as complex and slow, has been driving stakeholders to embrace cloud-based solutions to bring efficiencies to the process, but one key bottleneck—study start-up (SSU)—has been largely overlooked. Current thinking looks to an improved SSU process as holding great promise for accelerating clinical trials.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: